Glutamate (Metabotropic) Group I Receptors

Metabotropic glutamate (mGlu) group I receptors are members of the metabotropic class of glutamate receptors, which also includes mGlu group II and mGlu group III receptors. mGlu group I receptors are divided into two subtypes, mGlu1 and mGlu5.

Products
Background
Literature
Gene Data

Agonists

Cat No Product Name / Activity
0284 (1S,3R)-ACPD
Group I and group II mGlu agonist; active isomer of (±)-trans-ACPD (Cat. No. 0187)
0187 (±)-trans-ACPD
Group I and II mGlu agonist
1049 CHPG
mGlu5 selective agonist
3695 CHPG Sodium salt
Selective mGlu5 agonist; sodium salt of CHPG (Cat. No. 1049)
0342 (RS)-3,5-DHPG
Selective group I mGlu agonist
0805 (S)-3,5-DHPG
Selective group I mGlu agonist; active enantiomer of 3,5-DHPG (Cat. No. 0342)
0324 (RS)-3-Hydroxyphenylglycine
Group I mGlu agonist
0326 (S)-3-Hydroxyphenylglycine
Group I mGlu agonist; active isomer of (RS)-3-Hydroxphenylglycine (Cat. No. 0324)
3331 NPEC-caged-(1S,3R)-ACPD
Caged (1S,3R)-ACPD
0188 L-Quisqualic acid
Group I mGlu agonist; also AMPA agonist
0162 S-Sulfo-L-cysteine sodium salt
Group I mGlu agonist

Inverse Agonists

Cat No Product Name / Activity
2501 Bay 36-7620
mGlu1 inverse agonist

Antagonists

Cat No Product Name / Activity
5229 ABP 688
High affinity human mGlu5 antagonist
2254 ACDPP hydrochloride
Selective mGlu5 antagonist
0904 AIDA
Potent and selective group I mGlu antagonist
0125 DL-AP3
Group I mGlu antagonist; also phosphoserine phosphatase inhibitor
5614 AZD 2066
mGlu5 antagonist; orally bioavailable and brain penetrant
5613 AZD 9272
Potent and selective mGlu5 antagonist; brain penetrant
0329 (S)-3-Carboxy-4-hydroxyphenylglycine
Group I mGlu antagonist; also group II mGlu agonist
0320 (S)-4-Carboxy-3-hydroxyphenylglycine
Group I mGlu antagonist; also group II mGlu agonist
0323 (S)-4-Carboxyphenylglycine
Competitive group I mGlu antagonist; also weak group II agonist
1028 CPCCOEt
Selective non-competitive mGlu1 antagonist
1009 E4CPG
Group I and II mGlu antagonist
1749 HexylHIBO
Group I mGlu antagonist
1750 (S)-HexylHIBO
Group I mGlu antagonist
2333 JNJ 16259685
Highly potent, mGlu1-selective non-competitive antagonist
1237 LY 367385
Selective mGlu1a antagonist
2390 LY 456236 hydrochloride
Selective mGlu1 antagonist
2196 3-MATIDA
Potent and selective mGlu1 antagonist
1212 MPEP hydrochloride
Potent mGlu5 antagonist; also positive allosteric modulator of mGlu4 receptors
2921 MTEP hydrochloride
Potent and selective mGlu5 antagonist
4134 NPS 2390
Group I mGlu antagonist
1027 PHCCC
Potent group I mGlu antagonist
1215 SIB 1757
Highly selective mGlu5 antagonist
1214 SIB 1893
mGlu5 antagonist; also positive allosteric modulator at mGlu4 receptors
3413 YM 202074
High affinity, selective mGlu1 antagonist
2986 YM 230888
Selective mGlu1 antagonist
2448 YM 298198 hydrochloride
Highly potent, selective non-competitive mGlu1 antagonist
2447 Desmethyl-YM 298198
Derivative of mGlu1 antagonist YM 298198 (Cat. No. 2448)

Modulators

Cat No Product Name / Activity
4416 ADX 10059 hydrochloride
Negative allosteric modulator of mGlu5 receptors
3235 CDPPB
Positive allosteric modulator of mGlu5 receptors
4787 CPPHA
Positive allosteric modulator of mGlu1 and mGlu5 receptors
1952 DCB
Allosteric modulator of mGlu5 receptors
1625 DFB
Positive allosteric modulator of mGlu5 receptors
1953 DMeOB
Negative allosteric modulator of mGlu5 receptors
2386 Fenobam
Potent and selective mGlu5 negative allosteric modulator (NAM)
5000 FTIDC
Potent and selective negative allosteric modulator of mGlu1 receptors; also mGlu1 inverse agonist
5275 LSN 2463359
Potent and selective positive allosteric modulator of mGlu5 receptors
4438 MFZ 10-7
Negative allosteric modulator of mGlu5 receptors
4348 Ro 01-6128
Positive allosteric modulator of mGlu1 receptors
4347 Ro 67-4853
Positive allosteric modulator of group I mGlu receptors
4346 Ro 67-7476
Positive allosteric modulator of mGlu1 receptors
4381 VU 0285683
Negative allosteric modulator of mGlu5 receptors
4437 VU 0357121
Positive allosteric modulator of mGlu5 receptors
4323 VU 0360172 hydrochloride
Positive allosteric modulator of mGlu5 receptors
4394 VU 0360223
Negative allosteric modulator of mGlu5 receptors
5322 VU 0409106
Potent and selective negative allosteric modulator of mGlu5 receptors
5693 VU 0409551
Selective positive allosteric modulator of mGlu5 receptors; brain penetrant and orally bioavailable
5379 VU 0469650 hydrochloride
Potent and selective negative allosteric modulator of mGlu1 receptors
5377 VU 0483605
Positive allosteric modulator of mGlu1 receptors
3325 VU 1545
Positive allosteric modulator of mGlu5 receptors
4458 VU 29
Potent positive allosteric modulator of mGlu5 receptors

Ligand Sets

Cat No Product Name / Activity
1826 Group I mGlu Receptor Tocriset™
Selection of 5 group I mGlu receptor ligands (Cat. Nos. 0805, 0188, 1237, 1212 and 0337)
1829 Mixed mGlu Receptor Tocriset™
Selection of 5 mixed mGlu receptor ligands (Cat. Nos. 0805, 0975, 0103, 0337 and 1209)

Metabotropic glutamate (mGlu) group I receptors are members of the metabotropic class of glutamate receptors, which also includes mGlu group II and mGlu group III receptors. mGlu group I receptors are divided into two subtypes, mGlu1 and mGlu5. Group I mGluRs are coupled to Gq/11, which activates phospholipase C. They are also associated with Na+ and K+ channels. Their action is generally excitatory, increasing conductance, causing more glutamate to be released from the presynaptic cell. They can also increase inhibitory postsynaptic potentials (IPSPs), inhibit glutamate release and modulate voltage-dependent calcium channels. Group I mGluRs, unlike other groups, are activated by 3,5-dihydroxyphenylglycine (DHPG), allowing their function to be isolated. The human genes for mGluR1 and mGluR5 receptors have been localized to chromosomes 6 (6q24) and 11 (11q14.3) respectively.

External sources of pharmacological information for Glutamate (Metabotropic) Group I Receptors :

Literature for Glutamate (Metabotropic) Group I Receptors

Tocris offers the following scientific literature for Glutamate (Metabotropic) Group I Receptors to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


GPCR

GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Pain

Pain Research Product Guide

A collection of over 250 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling
Metabotropic Glutamate Receptors

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Addiction

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Depression

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Epilepsy

Epilepsy Poster

Epilepsy is a brain disease that affects 60 million people globally. More than 20 anti-seizure drugs are currently available, but these do not address the underlying causes of the condition. This poster summarizes current knowledge about the development of the condition and highlights some approaches that have disease-modifying effects in proof-of-concept studies.

Huntington's Disease

Huntington's Disease Poster

Huntington's disease (HD) is a monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the MSN intracellular signaling pathways implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.

Learning & Memory

Learning & Memory Poster

Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.

Pain

Pain Poster

Peripheral sensitization is the reduction in the threshold of excitability of sensory neurons that results in an augmented response to a given external stimulus. This poster outlines the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization. The role of ion channels, GPCRs, neurotrophins, and cytokines in sensory neurons are also described.

Parkinson's

Parkinson's Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.

Glutamate (Metabotropic) Group I Receptor Gene Data

Gene Species Gene Symbol Gene Accession No. Protein Accession No.
mGlu1 Human GRM1 NM_000838 Q13255
Mouse Grm1 NM_001114333 P97772
Rat Grm1 NM_017011 P23385
mGlu5 Human GRM5 NM_000842 P41594
Mouse Grm5 NM_001081414 Q3UVX5
Rat Grm5 NM_017012 P31424